EditorialFacing cardiovascular risk in Ibero-AmericaLa realidad del riesgo cardiovascular en Iberoamérica
Section snippets
CONCLUSIONS
The results from the large international epidemiological and clinical studies that we have reviewed demonstrate that, while in HICs cancer has replaced CVD as the leading cause of death, in MICs and LICs, CVD remains the leading cause of morbidity and mortality. In LICs and MICs, the main risk factors identified for death from any cause and CVD are low educational level, HTN, and factors linked to socioeconomic status, such as poor diet and household pollution due to the use of solid fuels. In
FUNDING
Population Health Research Institute (PHRI), Hamilton, Canada, and Secretaría de Salud de Santander and COLCIENCiAS, Colombia. Grant n.° 651777758228.
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
References (16)
- et al.
Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015
J Am Coll Cardiol.
(2017) - et al.
Estimación del riesgo cardiovascular de por vida (IBERLIFERISK): una herramienta nueva en prevención primaria de las enfermedades cardiovasculares
Rev Esp Cardiol.
(2019) - et al.
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study
Lancet.
(2015) - et al.
Association of handgrip strength to cardiovascular mortality in pre-diabetic and diabetic patients: a subanalysis of the ORIGIN trial
Int J Cardiol.
(2014) Cardiometabolic disease in latin america: the role of fetal programming in response to maternal malnutrition
Rev Esp Cardiol.
(2009)- et al.
A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial
Lancet.
(2019) - et al.
The spectrum of the dyslipidemia in Colombia: The PURE study
Int J Cardiol.
(2019) - et al.
Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
Lancet Glob Health.
(2018)
There are more references available in the full text version of this article.
Cited by (0)
© 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.